Currently, the main hurdle in the tissue engineering field is how to provide sufficient blood supply to grafted tissue substitutes in the early post-transplanted period. For three-dimensional, cell-dense, thick tissues to survive after transplantation, treatments are required for hypoxia, nutrient insufficiency, and the accumulation of waste products. In this study, a biomacromolecular layer-by-layer coating process of chitosan/heparin onto a decellularized extracellular bone matrix was designed to accelerate the blood perfusion and re-endothelialization process. The results of in vitro measurements of the activated partial thromboplastin time supported the theory that the combination of chitosan and heparin could bring both anticoagulation and hemocompatibility to the scaffold. A rabbit bone defect model was established for further evaluation of the application of this kind of surface-modified scaffold in vivo. The final results of computed tomography (CT) perfusion imaging and histological examination proved that this facile coating approach could significantly promote blood perfusion and re-endothelialization in the early post-transplanted period compared with an acellular bone matrix due to its much-improved anticoagulation property.
MarcacciM., KonE., MoukhachevV., LavroukovA., KutepovS., QuartoR.et al.Stem cells associated with macroporous bioceramics for long bone repair: 6 to 7 year outcome of a pilot clinical study. Tissue Eng, 13:947. 2007.
3.
ZhangZ.Y., TeohS.H., ChongM.S., LeeE.S., TanL.G., MattarC.N.et al.Neo-vascularization and bone formation mediated by fetal mesenchymal stem cell tissue-engineered bone grafts in critical-size femoral defects. Biomaterials, 31:608. 2010.
4.
BumaP., SchreursW., VerdonschotN.Skeletal tissue engineering from in vitro studies to large animal models. Biomaterials, 25:1487. 2004.
5.
NomiM., AtalaA., CoppiP.D., SokerS.Principals of neovascularization for tissue engineering. Mol Aspects Med, 23:463. 2002.
6.
CassellO.C., HoferS.O., MorrisonW.A., KnightK.R.Vascularisation of tissue engineered grafts: the regulation of angiogenesis in reconstructive surgery and in disease states. Br J Plast Surg, 55:603. 2002.
7.
ShastriV.P.Future of regenerative medicine: challenges and hurdles. Artif Organs, 30:828. 2006.
8.
LaschkeM.W., HarderY., AmonM., MartinI., FarhadiJ., RingA.et al.Angiogenesis in tissue engineering: breathing life into constructed tissue substitutes. Tissue Eng, 12:2093. 2006.
9.
VoglerE.A., SiedleckiC.A.Contact activation of blood–plasma coagulation. Biomaterials, 30:1857. 2009.
10.
TadashiSasagawa, TatsuyaShimizu, SachikoSekiya, YujiHaraguchi, MasayukiYamato. Design of prevascularized three-dimensional cell-dense tissues using a cell sheet stacking manipulation technology. Biomaterials, 31:1646. 2010.
11.
RatnerB.D.The catastrophe revisited: blood compatibility in the 21st century. Biomaterials, 28:5144. 2007.
12.
McFaddenE.P., StabileE., RegarE., CheneauE., OngA.T., KinnairdT.et al.Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet, 364:1519. 2004.
13.
SerruysP.W., EmanuelssonH., van der GiessenW., LunnA.C., KiemeneyF., MacayaC.et al.Heparin-coated Palmaz–Schatz stents in human coronary arteries: early outcome of the Benestent-II pilot study. Circulation, 93:412. 1996.
14.
SerruysP.W., van HoutB., BonnierH., LegrandV., GarciaE., MacayaC.et al.Randomised comparison of implantation of heparin coated stents with balloon angioplasty in selected patients with coronary artery disease (Bene-stent II)Lancet, 352:673. 1998.
15.
ChenH., ChenY., SheardownH., BrookM.A.Immobilization of heparin on a silicone surface through a heterobifunctional PEG spacer. Biomaterials, 26:7418. 2005.
16.
LiuQ., DingJ., ManteF.K., WunderS., BaranG.R.The role of surface functional groups in calcium phosphate nucleation on titanium foil: a self-assembled monolayer technique. Biomaterials, 23:3103. 2002.
17.
FuJ.H., JiJ., YuanW.Y., ShenJ.C.Construction of anti-adhesive and antibacterial multilayer films via layer-by-layer assembly of heparin and chitosan. Biomaterials, 26:6684. 2005.
18.
MengS., LiuZ., ShenL., GuoZ., ChouL.L., ZhongW.et al.The effect of a laye-by-layer chitosan–heparin coating on the endothelialization and coagulation properties of a coronary stent system. Biomaterials, 30:2276. 2009.
19.
ChristensenK., LarssonR., EmanuelssonH.K., ElgueG., LarssonA.Heparin coating of the stent graft-effects on platelets, coagulation and complement activation. Biomaterials, 22:349. 2001.
20.
ChenJ.L., LiQ.L., ChenJ.Y., ChenC., HuangN.Improving blood-compatibility of titanium by coating collagen–heparin multilayers. Appl Surf Sci, 255:6894. 2009.
21.
PikeD.B., CaiS., PomraningK.R., FirpoM.A., FisherR.J., ShuX.Z.et al.Heparin regulated release of growth factors in vitro and angiogenic response in vivo to implanted hyaluronan hydrogels containing VEGF and bFGF. Biomaterials, 27:5242. 2006.
22.
YangZhilu, WangJin, LuoRifang, ManfredF. Maitz. The covalent immobilization of heparin to pulsed-plasma polymeric allylamine films on 316L stainless steel and the resulting effects on hemocompatibility. Biomaterials, 31:2072. 2010.
23.
RouwkemaJ., de BoerJ., Van BlitterswijkC.A.Endothelial cells assemble into a 3-dimensional prevascular network in a bone tissue engineering construct. Tissue Eng, 12:2685. 2006.
24.
YuanJ., CuiL., ZhangW.J., LiuW., CaoY.Repair of canine mandibular bone defects with bone marrow stromal cells and porous b-tricalcium phosphate. Biomaterials, 28:1005. 2007.
25.
QiangC., ZailiangY., ShijinS.et al.Adipose-derived stem cells modified genetically in vivo promote reconstruction of bone defects. Cytotherapy, 12:831. 2010.
26.
GorbetM.B., SeftonM.V.Biomaterial associated thrombosis: roles of coagulation factors, complement, platelets and leukocytes. Biomaterials, 25:5681. 2004.
27.
TsengP.Y., ReleS.S., SunX.L., ChaikofE.L.Membrane mimetic films containing thrombomodulin and heparin inhibit tissue factor induced thrombin generation in a flow model. Biomaterials, 27:2637. 2006.
28.
WernerC., MaitzM.F., SperlingC.Current strategies towards hemocompatible coatings. J Mater Chem, 17:3376. 2007.
29.
TakadaT., KatagiriT., IfukuM.et al.Sulfated polysaccharides enhance the biological activities of bone morphogenetic proteins. J Biol Chem, 278:43229. 2003.
VrolixM.C.M., LegrandV.M., ReiberJ.H.C., GrollierG., SchalijM.J., BrunelP.et al.Heparin coated Wiktor stents in human coronary arteries (MENTOR trial)Am J Cardiol, 86:385. 2000.
32.
ChenH., ChenY., SheardownH., BrookM.A.Immobilization of heparin on a silicone surface through a heterobifunctional PEG spacer. Biomaterials, 26:7418. 2005.
33.
LiuQ., DingJ., ManteF.K., WunderS., BaranG.R.The role of surface functional groups in calcium phosphate nucleation on titanium foil: a self-assembled monolayer technique. Biomaterials, 23:3103. 2002.
34.
FuJ.H., JiJ., YuanW.Y., ShenJ.C.Construction of anti-adhesive and antibacterial multilayer films via layer-by-layer assembly of heparin and chitosan. Biomaterials, 26:6684. 2005.
35.
MengSheng, LiuZongjun, ShenLi. The effect of a layer-by-layer chitosan heparin coating on the endothelialization and coagulation properties of a coronary stent system. Biomaterials, 30:2276. 2009.
36.
JiangT., KhanY., NairL.S., Abdel-FattahW.I., LaurencinC.T.Functionalization of chitosan/poly(lactic acid-glycolic acid) sintered microsphere scaffolds via surface heparinization for bone tissue engineering. J Biomed Mater Res A, 93:1193. 2010.
37.
FuJ.H., JiJ., YuanW.Y., ShenJ.C.Construction of anti-adhesive and antibacterial multilayer films via layer-by-layer assembly of heparin and chitosan. Biomaterials, 26:6684. 2005.
TsaiA.G., JohnsonP.C., IntagliettaM.Oxygen gradients in the microcirculation. Physiol Rev, 83:933. 2003.
40.
MuschlerG.F., NakamotoC., GriffithL.G.Engineering principles of clinical cell-based tissue engineering. J Bone Joint Surg Am, 86-A:1541. 2004.
41.
PeterR. Hoskins. Simulation and validation of arterial ultrasound imaging and blood flow. Ultrasound Med Biol, 34:693. 2008.
42.
BollandB.J.R.F., KanczlerJ.M., DunlopD.G., OreffoR.O.C.Development of in vivo μCT evaluation of neovascularisation in tissue engineered bone constructs. Bone, 43:195. 2008.
43.
AntonellaBisio, SaraGuglieri, MartaFrigerio, GiangiacomoTorri, ElenaVismara, UmbertoCornelli, DonataBensi, SergioGonellad, Luigi DeAmbrosi. Controlled γ-ray irradiation of heparin generates oligosaccharides enriched in highly sulfated sequences. Carbohydrate Polymers, 55:101. 2004.
44.
DαmA.M., GazsóE.G., KaewpilaS., MaschekI.Radiation sterilization dose calculation for heparin and aprotinin based on ISO Method 1. Int J Pharm, 121:245. 1995.
45.
NobuhikoMiyazawa, Ali SyedArbab, TakakoUmeda, IwaoAkiyama. Perfusion CT investigation of chronic internal carotid artery occlusion: comparison with SPECT. Clin Neurol Neurosurg, 108:11. 2005.
46.
DaisukeTakenaka, YoshiharuOhnoa, HisanobuKoyama, MunenobuNogami, YumikoOnishi. Co-registered perfusion SPECT/CT: utility for prediction of improved postoperative outcome in lung volume reduction surgery candidates. Eur J Radiol, 74:465. 2010.
47.
HongZhao, JingshanGong, YanWang, ZuoquanZhang, PeixinQin. Renal hemodynamic changes with aging: a preliminary study using CT perfusion in the healthy elderly. Clin Imaging, 34:247. 2010.
48.
AndreasK amena, FlorianStreitparth, ChristianGrieser, LukasLehmkuhlet al.Dynamic perfusion CT: optimizing the temporal resolution for the calculation of perfusion CT parameters in stroke patients. Eur J Radiol, 64:111. 2007.
49.
LisaTang, GhassanHamarneh, AnnaCeller. Validation of mutual information based registration of CT and bone SPECT images in dual isotope studies. Computer Methods Programs Biomed, 92:173. 2008.
RobertsH.C., DillonW.P., SmithW.S.Dynamic CT perfusion to assess the effect of carotid revascularization in chronic cerebral ischemia. Am J Neuroradiol, 21:421. 2000.
52.
Young HanLee, WoocheolKwon, Myung SoonKim, Young JuKim, Myeong SubLee. Lung perfusion CT: the differentiation of cavitary mass. Eur J Radiol, 73:59. 2010.
